semaglutide infection Frontiers What Is the Dark Side

For weight management or more pronounced glucose control, the dose may be gradually increased to 1.0 mg or higher over several weeks

They can also delay stomach emptying and cause nausea, which may result in drinking less fluid GLP-1 medications seem to lower blood pressure in some patients, which can also make patients susceptible to dizzy spells and fainting

Those with a history of motion sickness or medication-induced nausea are also at higher risk

Wegovy, Novo Nordisks brand name weight loss version of semaglutide, is currently manufactured in the following five doses

Wegovy works by suppressing appetite, helping individuals consume fewer calories